1. Home
  2. SRDX vs LAND Comparison

SRDX vs LAND Comparison

Compare SRDX & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • LAND
  • Stock Information
  • Founded
  • SRDX 1979
  • LAND 1997
  • Country
  • SRDX United States
  • LAND United States
  • Employees
  • SRDX N/A
  • LAND N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • LAND Real Estate Investment Trusts
  • Sector
  • SRDX Health Care
  • LAND Real Estate
  • Exchange
  • SRDX Nasdaq
  • LAND Nasdaq
  • Market Cap
  • SRDX 415.4M
  • LAND 360.0M
  • IPO Year
  • SRDX 1998
  • LAND 2013
  • Fundamental
  • Price
  • SRDX $34.15
  • LAND $9.14
  • Analyst Decision
  • SRDX Buy
  • LAND
  • Analyst Count
  • SRDX 3
  • LAND 0
  • Target Price
  • SRDX $43.00
  • LAND N/A
  • AVG Volume (30 Days)
  • SRDX 342.3K
  • LAND 448.3K
  • Earning Date
  • SRDX 08-08-2025
  • LAND 08-07-2025
  • Dividend Yield
  • SRDX N/A
  • LAND 6.12%
  • EPS Growth
  • SRDX N/A
  • LAND N/A
  • EPS
  • SRDX N/A
  • LAND N/A
  • Revenue
  • SRDX $120,801,000.00
  • LAND $72,691,000.00
  • Revenue This Year
  • SRDX N/A
  • LAND N/A
  • Revenue Next Year
  • SRDX $3.38
  • LAND $15.78
  • P/E Ratio
  • SRDX N/A
  • LAND N/A
  • Revenue Growth
  • SRDX N/A
  • LAND N/A
  • 52 Week Low
  • SRDX $26.00
  • LAND $8.47
  • 52 Week High
  • SRDX $40.39
  • LAND $14.88
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 43.47
  • LAND 46.14
  • Support Level
  • SRDX $34.99
  • LAND $8.82
  • Resistance Level
  • SRDX $37.77
  • LAND $9.24
  • Average True Range (ATR)
  • SRDX 1.54
  • LAND 0.23
  • MACD
  • SRDX -0.54
  • LAND 0.07
  • Stochastic Oscillator
  • SRDX 3.28
  • LAND 87.24

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: